Intercept Pharmaceuticals Investor Relations Material
Latest events
Q2 2023
Intercept Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intercept Pharmaceuticals Inc
Access all reports
Intercept Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for chronic liver diseases. The company’s research includes treatments for conditions such as primary biliary cholangitis and nonalcoholic steatohepatitis. Intercept Pharmaceuticals Inc is headquartered in Morristown, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ICPT
Country
🇺🇸 United States